Pathology explained · Tumour markers
A CA125 that’s slowly rising — but the scans are clear.
It’s an unsettling combination: a blood marker creeping upward while every ultrasound and scan comes back normal. The reassuring reality is that CA125 is not ovary-specific — it lifts for many ordinary reasons. Here’s how to read the situation and what’s worth testing alongside it.
The short version
CA125 is shed by the linings of body cavities, not just the ovary. A slow rise with clean imaging is most often benign — the priority is to trend it and add more specific tests, not to panic over one number.
U/mL is the usual reference, but the rate of change matters more than any single value.
What CA125 actually is
CA125 is a large protein (MUC16) shed by cells that line the body’s internal cavities — the peritoneum, pleura and pericardium — as well as tissues of the female reproductive tract (endometrium, fallopian tubes). It became famous as an ovarian-cancer monitoring marker, but that fame is misleading: almost anything that irritates, inflames or stretches those linings can raise it.
That’s why CA125 is a useful tool for tracking a known condition over time, but a blunt instrument for screening — a single raised value, especially in a premenopausal woman, has many possible explanations.
Why CA125 can rise when scans are clear
When imaging shows nothing, the cause is usually a process that irritates a lining without forming a mass an ultrasound would catch. These fall into a few groups:
Benign gynaecological causes most common, premenopausal
Endometriosis and adenomyosis are the classic culprits behind a persistent mild-to-moderate elevation — and both can be present without an obvious mass on standard ultrasound. Also common: uterine fibroids, ovarian or functional cysts, pelvic inflammatory disease, and the normal rise that happens during menstruation and in early pregnancy.
Irritation of the peritoneum or pleura
Because the lining itself produces CA125, anything that inflames or stretches it can raise the marker: recent abdominal or pelvic surgery, diverticulitis or other peritoneal inflammation, and fluid build-up such as ascites or a pleural effusion.
Other organ systems & whole-body factors
Conditions well away from the pelvis can lift CA125 — notably liver disease (cirrhosis, hepatitis), heart failure, pancreatitis and kidney disease, largely through fluid shifts and serosal stretch. Add general inflammation, normal biological fluctuation, and assay/lab variation between draws, and you have many ways for the number to drift up without cancer.
What else is worth testing
Rather than repeating the same CA125 in isolation, the more informative move is to add markers that narrow the source and to investigate by symptom:
HE4 + ROMA
HE4 is more specific to ovarian malignancy and — usefully — is not raised by endometriosis or fibroids. Combined with CA125 and menopausal status, the ROMA index gives a far better risk read than CA125 alone.
CEA & CA19-9
These help distinguish a gastrointestinal or pancreatic source from a gynaecological one when the picture is unclear.
Inflammation & organ panels
CRP and ESR for systemic inflammation; liver, kidney and heart-failure markers if there are matching symptoms — since each can independently lift CA125.
Targeted imaging by symptom
If endometriosis or adenomyosis is suspected, a pelvic MRI sees what standard ultrasound can miss; broader imaging only if an extra-pelvic source is suggested.
Reading the trend — the part that matters most
A single CA125 is noisy. What specialists actually watch is the trajectory over time:
| Principle | Why it matters |
|---|---|
| Trend, not snapshot | Rate of change and doubling time are far more meaningful than one value. A slow drift behaves very differently from a rapid climb. |
| Same cycle phase | CA125 fluctuates across the menstrual cycle and peaks during menses. Drawing at a consistent point (e.g. days 1–5, or the same mid-cycle day each time) removes a major source of false “rises”. |
| Same lab & assay | Different assays aren’t perfectly interchangeable. Tracking through one lab keeps the trend honest. |
| Context every time | Note recent surgery, infection, cycle day, pregnancy and other illness at each draw — any can nudge the number. |
Reassurance — and when to escalate
In a premenopausal woman with clear imaging, a slowly rising CA125 is most often benign, with endometriosis, adenomyosis and fibroids leading the list. The standard, sensible approach is structured vigilance: trend the marker, add more specific tests, and investigate symptoms — not immediate alarm.
The picture deserves closer, prompt specialist review when there is a rapid rise rather than a slow drift, an elevation after menopause, a markedly raised HE4 / ROMA result, or new persistent symptoms such as bloating, early satiety, pelvic pain or changes in appetite.
Sources & further reading
Drawn from peer-reviewed literature retrieved from PubMed on CA125 biology, its benign causes of elevation, and the role of HE4 and the ROMA algorithm — plus Australian patient-facing references.
- Sikaris KA. CA125 — a test with a change of heart. Heart, Lung & Circulation. 2010;20(10):634–40. doi:10.1016/j.hlc.2010.08.001 benign causes: liver, peritoneal, cardiac
- Dochez V, Caillon H, Vaucel E, et al. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Journal of Ovarian Research. 2019;12(1):28. doi:10.1186/s13048-019-0503-7
- Janas Ł, Stachowiak G, Głowacka E, et al. The use of CA125, HE4, ROMA, RMI and subjective assessment in preoperative diagnosing of ovarian tumors. Ginekologia Polska. 2023;95(5):321–7. doi:10.5603/GP.a2022.0144
- Drake J. Diagnosis and management of the adnexal mass. American Family Physician. 1998;57(10):2471–80. PMID 9614415
- Pathology Tests Explained (Australia) — “CA125” test entry. pathologytestsexplained.org.au
Frequently asked questions
Should I worry about a slowly rising CA125 if my scans are clear?
In a premenopausal woman with normal imaging, a slowly rising CA125 is most often benign. CA125 is not ovary-specific, it is shed by the linings of the body's cavities and lifts whenever those linings are irritated, so endometriosis, adenomyosis, fibroids, menstruation and many other benign causes can raise it. A clear scan rules out a visible mass but not these benign processes. The sensible approach is structured vigilance: trend the marker and add more specific tests rather than panic over one value.
What else can raise CA125 besides ovarian cancer?
Many ordinary things can lift CA125 because the marker reflects irritation of body-cavity linings in general. Common causes include endometriosis, adenomyosis, fibroids, ovarian cysts, pelvic inflammatory disease, normal menstruation and early pregnancy. Irritation of the peritoneum or pleura from recent surgery, diverticulitis or fluid build-up can also raise it, as can liver disease, heart failure, pancreatitis and kidney disease through fluid shifts. General inflammation and lab-to-lab assay variation add further noise.
What tests are worth adding to a rising CA125?
Rather than repeating CA125 in isolation, more informative steps are to add markers that narrow the source. HE4 is more specific to ovarian malignancy and is not raised by endometriosis or fibroids, and combined with CA125 and menopausal status the ROMA index gives a better risk read. CEA and CA19-9 help distinguish a gastrointestinal source, while CRP and ESR assess inflammation. A pelvic MRI can see what standard ultrasound misses. Your specialist guides which to use.
Reviewed by Rohan Smith, BHSc Nutritional Medicine · Elemental Health & Nutrition, Adelaide. Last reviewed 14 June 2026.
Important: This summary is general information, not personalised medical advice, diagnosis, or a treatment protocol. Speak with a qualified practitioner about your individual situation. Book a consultation →